1
|
Goulay R, Fémy F, Nervo A, Valentino S, Madi M, Joly AL, Servonnet A, Nachon F, Reymond C, Jaffré N. Baseline physiological data from anesthetized pigs in a VX intoxication model. Toxicol Lett 2024; 397:117-128. [PMID: 38768837 DOI: 10.1016/j.toxlet.2024.05.012] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/28/2023] [Revised: 05/10/2024] [Accepted: 05/17/2024] [Indexed: 05/22/2024]
Abstract
Over the past fifty years, swine models have been used for organophosphorus intoxication studies. Among these studies and others on the swine model in general, some physiological data, especially cholinesterase activity highly impacted by organophosphorus compounds like nerve agent VX, still need to be completed. To support and compare our model to others, we have published the experimental protocol, the physiological values of 31 juvenile anesthetized pigs, and the 6 h-follow-up of six supplementary anesthetized control animals and 7 VX-intoxicated pigs. We reported hemodynamics and respiratory parameters, blood levels in several biochemical parameters, blood gas, and complete blood count and compared them to the literature. We also focused on tissue and blood cholinesterase activities and detailed them for acetylcholinesterase and butyrylcholinesterase. After establishing a broad physiological data set consistent with the literature, we reported several cardio-respiratory parameters that seem more affected by an organophosphate intoxication, like heart rate, arterial blood pressure, cardiac output, and respiratory rate. Within the blood, oxygen saturation (SpO2), lactatemia, base excess, and glycemia can also be measured and associated with the other parameters to evaluate the life-threatening status. This swine model is currently used to develop and evaluate medical countermeasures against organophosphate nerve agent intoxications.
Collapse
Affiliation(s)
- R Goulay
- Department of Toxicology and Chemical Risks, French Armed Forces Biomedical Research Institute, Brétigny Sur Orge, France
| | - F Fémy
- Department of Toxicology and Chemical Risks, French Armed Forces Biomedical Research Institute, Brétigny Sur Orge, France; Departments of Emergency, Georges Pompidou European Hospital, Assistance Publique - Hôpitaux de Paris, France
| | - A Nervo
- Department of Toxicology and Chemical Risks, French Armed Forces Biomedical Research Institute, Brétigny Sur Orge, France
| | - S Valentino
- Department of Toxicology and Chemical Risks, French Armed Forces Biomedical Research Institute, Brétigny Sur Orge, France
| | - M Madi
- Department of Toxicology and Chemical Risks, French Armed Forces Biomedical Research Institute, Brétigny Sur Orge, France
| | - A-L Joly
- Department of Toxicology and Chemical Risks, French Armed Forces Biomedical Research Institute, Brétigny Sur Orge, France
| | - A Servonnet
- Department of Toxicology and Chemical Risks, French Armed Forces Biomedical Research Institute, Brétigny Sur Orge, France
| | - F Nachon
- Department of Toxicology and Chemical Risks, French Armed Forces Biomedical Research Institute, Brétigny Sur Orge, France
| | - C Reymond
- Department of Toxicology and Chemical Risks, French Armed Forces Biomedical Research Institute, Brétigny Sur Orge, France
| | - N Jaffré
- Department of Toxicology and Chemical Risks, French Armed Forces Biomedical Research Institute, Brétigny Sur Orge, France.
| |
Collapse
|
2
|
Kumari K, Singh A, Swamy S, Singhar RS, Thakur S. Use of enzymatic biomarkers of Labeo rohita to study the effect of polybrominated diphenyl ether (BDE- 209) via dietary exposure in laboratory conditions. ENVIRONMENTAL MONITORING AND ASSESSMENT 2022; 194:499. [PMID: 35695941 DOI: 10.1007/s10661-022-09963-0] [Citation(s) in RCA: 6] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/19/2021] [Accepted: 03/19/2022] [Indexed: 06/15/2023]
Abstract
Fishes have been widely used as a representative to estimate the health of an aquatic ecosystem. In the present study, Labeo rohita was selected for biomarker study against decabromodiphenyl ether (BDE-209), a persistent organic pollutant (POP), as it is a widely used Indian carp. The results suggested significant effects on the optimum metabolism of Labeo rohita. After 48 to 72 h of exposure, most of the biomarkers such as lactate dehydrogenase (LDH), creatine kinase (CK), serum glutamic pyruvic transaminase (SGPT), serum glutamic oxaloacetic transaminase (SGOT), and hepatosomatic index (HSI) increased drastically indicating the higher index of tissue and liver damage. On the contrary, succinic dehydrogenase (SDH), acetylcholinesterase (AChE), and alkaline phosphatase (ALP) showed a reverse trend suggesting the shifting of fish metabolism towards anaerobic respiration mode because of induced stress. Increased catalase (CAT) activity was also observed, which indicated increased abundance of reactive hydroxyl species and therefore a possible oxidative stress in fishes. It is further suggested to understand and examine the biotransformation characteristics and degradation pathways of polybrominated diphenyl ether (PBDE)s, which would be useful to comprehend their environmental fate.
Collapse
Affiliation(s)
- Kanchan Kumari
- CSIR-National Environmental Engineering Research Institute, Kolkata Zonal Centre, Kolkata, 700 107, West Bengal, India.
- Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, 201 002, India.
| | - Anshika Singh
- CSIR-National Environmental Engineering Research Institute, Nagpur, 440 020, India
- Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, 201 002, India
| | - Senerita Swamy
- CSIR-National Environmental Engineering Research Institute, Nagpur, 440 020, India
| | | | - Surabhi Thakur
- CSIR-National Environmental Engineering Research Institute, Nagpur, 440 020, India
| |
Collapse
|
3
|
Morgan JE, Wilson SC, Travis BJ, Bagri KH, Pagarigan KT, Belski HM, Jackson C, Bounader KM, Coppola JM, Hornung EN, Johnson JE, McCarren HS. Refractory and Super-Refractory Status Epilepticus in Nerve Agent-Poisoned Rats Following Application of Standard Clinical Treatment Guidelines. Front Neurosci 2021; 15:732213. [PMID: 34566572 PMCID: PMC8462486 DOI: 10.3389/fnins.2021.732213] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/28/2021] [Accepted: 08/16/2021] [Indexed: 12/24/2022] Open
Abstract
Nerve agents (NAs) induce a severe cholinergic crisis that can lead to status epilepticus (SE). Current guidelines for treatment of NA-induced SE only include prehospital benzodiazepines, which may not fully resolve this life-threatening condition. This study examined the efficacy of general clinical protocols for treatment of SE in the specific context of NA poisoning in adult male rats. Treatment with both intramuscular and intravenous benzodiazepines was entirely insufficient to control SE. Second line intervention with valproate (VPA) initially terminated SE in 35% of rats, but seizures always returned. Phenobarbital (PHB) was more effective, with SE terminating in 56% of rats and 19% of rats remaining seizure-free for at least 24 h. The majority of rats demonstrated refractory SE (RSE) and required treatment with a continuous third-line anesthetic. Both ketamine (KET) and propofol (PRO) led to high levels of mortality, and nearly all rats on these therapies had breakthrough seizure activity, demonstrating super-refractory SE (SRSE). For the small subset of rats in which SE was fully resolved, significant improvements over controls were observed in recovery metrics, behavioral assays, and brain pathology. Together these data suggest that NA-induced SE is particularly severe, but aggressive treatment in the intensive care setting can lead to positive functional outcomes for casualties.
Collapse
Affiliation(s)
- Julia E Morgan
- Neuroscience Department, US Army Medical Research Institute of Chemical Defense, Aberdeen Proving Ground, MD, United States
| | - Sara C Wilson
- Neuroscience Department, US Army Medical Research Institute of Chemical Defense, Aberdeen Proving Ground, MD, United States
| | - Benjamin J Travis
- Neuroscience Department, US Army Medical Research Institute of Chemical Defense, Aberdeen Proving Ground, MD, United States
| | - Kathryn H Bagri
- Neuroscience Department, US Army Medical Research Institute of Chemical Defense, Aberdeen Proving Ground, MD, United States
| | - Kathleen T Pagarigan
- Neuroscience Department, US Army Medical Research Institute of Chemical Defense, Aberdeen Proving Ground, MD, United States
| | - Hannah M Belski
- Neuroscience Department, US Army Medical Research Institute of Chemical Defense, Aberdeen Proving Ground, MD, United States
| | - Cecelia Jackson
- Neuroscience Department, US Army Medical Research Institute of Chemical Defense, Aberdeen Proving Ground, MD, United States
| | - Kevin M Bounader
- Neuroscience Department, US Army Medical Research Institute of Chemical Defense, Aberdeen Proving Ground, MD, United States
| | - Jessica M Coppola
- Neuroscience Department, US Army Medical Research Institute of Chemical Defense, Aberdeen Proving Ground, MD, United States
| | - Eden N Hornung
- Neuroscience Department, US Army Medical Research Institute of Chemical Defense, Aberdeen Proving Ground, MD, United States
| | - James E Johnson
- Comparative Pathology Department, US Army Medical Research Institute of Chemical Defense, Aberdeen Proving Ground, MD, United States
| | - Hilary S McCarren
- Neuroscience Department, US Army Medical Research Institute of Chemical Defense, Aberdeen Proving Ground, MD, United States
| |
Collapse
|
4
|
Therkorn J, Drewry DG, Tiburzi O, Astatke M, Young C, Rainwater-Lovett K. Review of Biomarkers and Analytical Methods for Organophosphate Pesticides and Applicability to Nerve Agents. Mil Med 2020; 185:e414-e421. [DOI: 10.1093/milmed/usz441] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/20/2019] [Accepted: 11/05/2019] [Indexed: 11/12/2022] Open
Abstract
Abstract
Introduction
Recent malicious use of chemical warfare agents (CWAs) is a reminder of their severity and ongoing threat. One of the main categories of CWAs is the organophosphate (OP) nerve agents. Presently, there is an urgent need to identify and evaluate OP nerve agent biomarkers that can facilitate identification of exposed individuals post-CWA incident. While exposures to OP nerve agents may be scenario-specific, the public is commonly exposed to OP compounds through the ubiquitous use of OP pesticides, which are chemically related to nerve agents. Therefore, a systematic literature review and methodological quality assessment were conducted for OP pesticide biomarker studies to serve as a baseline to assess if these approaches may be adapted to OP nerve agent exposures.
Materials and Methods
We conducted a systematic literature review to identify biomarkers of OP pesticide exposures. English language studies of any design that reported primary data on biomarkers for exposures in nonhuman primates or adult human study participants were eligible for inclusion. Using standard criteria for assessing the completeness of reported analytical methods, the quality of study methods was critically evaluated.
Results
A total of 1,044 studies of biomarkers of OP pesticide exposure were identified, of which 75 articles satisfied the inclusion and exclusion criteria. These studies described 143 different analyte/sample matrix combinations: 99 host-based biomarkers, 28 metabolites, 12 pesticides, and 4 adducts. The most commonly reported biomarkers were dialkyl phosphate urinary metabolites (22 studies), blood acetylcholinesterase, and plasma butyrylcholinesterase (26 studies each). None of the assessed quality review criteria were fully addressed by all identified studies, with almost all criteria scoring less than 50%.
Conclusion
Cholinesterase activity may have utility for identifying individuals with exposures surpassing a given threshold of OP nerve agent, but further investigation of how acetylcholinesterase and butyrylcholinesterase levels correlate with observed patient symptoms may be required to ensure accuracy of results. As CWAs and nerve agents are more readily used, more standardized reporting of biomarker measurements are needed to develop new approaches for OP nerve agent biomarkers.
Collapse
Affiliation(s)
- Jennifer Therkorn
- Asymmetric Operations Sector, Johns Hopkins Applied Physics Laboratory, 11100 Johns Hopkins Road, Laurel, MD 20723
| | - David G Drewry
- Asymmetric Operations Sector, Johns Hopkins Applied Physics Laboratory, 11100 Johns Hopkins Road, Laurel, MD 20723
| | - Olivia Tiburzi
- Asymmetric Operations Sector, Johns Hopkins Applied Physics Laboratory, 11100 Johns Hopkins Road, Laurel, MD 20723
| | - Mekbib Astatke
- Asymmetric Operations Sector, Johns Hopkins Applied Physics Laboratory, 11100 Johns Hopkins Road, Laurel, MD 20723
| | - Charles Young
- Asymmetric Operations Sector, Johns Hopkins Applied Physics Laboratory, 11100 Johns Hopkins Road, Laurel, MD 20723
| | - Kaitlin Rainwater-Lovett
- Asymmetric Operations Sector, Johns Hopkins Applied Physics Laboratory, 11100 Johns Hopkins Road, Laurel, MD 20723
| |
Collapse
|
5
|
Reymond C, Jaffré N, Taudon N, Menneteau M, Chaussard H, Denis J, Castellarin C, Dhote F, Dorandeu F. Superior efficacy of HI-6 dimethanesulfonate over pralidoxime methylsulfate against Russian VX poisoning in cynomolgus monkeys (Macaca fascicularis). Toxicology 2018; 410:96-105. [PMID: 30218682 DOI: 10.1016/j.tox.2018.09.005] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/13/2018] [Revised: 09/06/2018] [Accepted: 09/09/2018] [Indexed: 11/30/2022]
Abstract
Organophosphorus nerve agents still represent a serious risk to human health. In the French armed forces, the current emergency treatment against OP intoxications is a fully licensed wet-dry dual-chambered autoinjector (Ineurope ®), that contains pralidoxime methylsulfate (2-PAM) to reactivate inhibited acetylcholinesterase (AChE), atropine sulfate (AS) and avizafone chlorhydrate (AVZ). While this treatment is effective against several of the known nerve agents, it shows little efficacy against the Russian VX (VR), one of the most toxic compounds. HI-6 dimethanesulfonate (HI-6 DMS) is an oxime able to reactivate in vitro and in vivo VR-inhibited AChE. To confirm the superiority of HI-6 DMS towards 2-PAM prior to licensing, we compared the two 3-drug-combinations (HI-6 vs 2-PAM, 33 and 18 mg/kg respectively, equimolar doses; AS/AVZ 0.25/0.175 mg/kg respectively) in VR-poisoned cynomolgus macaques, the model required by the French drug regulatory agency. In parallel we performed HI-6 pharmacokinetics analysis using a one compartment model. A better efficacy of the HI-6 DMS combination was clearly observed: up to 5 LD50 of VR (i.m.), a single administration of the HI-6 DMS combination, shortly after the onset of clinical signs, prevented death of the four intoxicated animals. Conversely 2-PAM only prevented death in one out of three subjects exposed to the same amount of VR. As expected with V agents, reinhibition of blood AChE was observed but without any apparent impact on the clinical recovery of the animals. A single administration of the HI-6 DMS combination was still but partially effective at 15 LD50 of VR, allowing a 50% survival rate.
Collapse
Affiliation(s)
- Chloé Reymond
- Institut de Recherche Biomédicale des Armées (IRBA), département de Toxicologie et Risques Chimiques, F-91 220 Brétigny-sur-Orge, France
| | - Nina Jaffré
- Institut de Recherche Biomédicale des Armées (IRBA), département de Toxicologie et Risques Chimiques, F-91 220 Brétigny-sur-Orge, France.
| | - Nicolas Taudon
- Institut de Recherche Biomédicale des Armées (IRBA), département des Plateformes et Recherche Technologique, F-91 220 Brétigny-sur-Orge, France
| | - Mathilde Menneteau
- Institut de Recherche Biomédicale des Armées (IRBA), département de Toxicologie et Risques Chimiques, F-91 220 Brétigny-sur-Orge, France
| | - Hervé Chaussard
- Institut de Recherche Biomédicale des Armées (IRBA), unité Animalerie, F-91 220 Brétigny-sur-Orge, France
| | - Josiane Denis
- Institut de Recherche Biomédicale des Armées (IRBA), département de Toxicologie et Risques Chimiques, F-91 220 Brétigny-sur-Orge, France
| | - Cédric Castellarin
- Institut de Recherche Biomédicale des Armées (IRBA), département des Plateformes et Recherche Technologique, F-91 220 Brétigny-sur-Orge, France
| | - Franck Dhote
- Institut de Recherche Biomédicale des Armées (IRBA), département de Toxicologie et Risques Chimiques, F-91 220 Brétigny-sur-Orge, France
| | - Frédéric Dorandeu
- Institut de Recherche Biomédicale des Armées (IRBA), département de Toxicologie et Risques Chimiques, F-91 220 Brétigny-sur-Orge, France; Ecole du Val-de-Grâce, 1 place Alphonse Laveran, 75230 Paris, France
| |
Collapse
|
6
|
The role of genetic background in susceptibility to chemical warfare nerve agents across rodent and non-human primate models. Toxicology 2017; 393:51-61. [PMID: 29113833 DOI: 10.1016/j.tox.2017.11.003] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/21/2017] [Revised: 10/13/2017] [Accepted: 11/02/2017] [Indexed: 11/22/2022]
Abstract
Genetics likely play a role in various responses to nerve agent exposure, as genetic background plays an important role in behavioral, neurological, and physiological responses to environmental stimuli. Mouse strains or selected lines can be used to identify susceptibility based on background genetic features to nerve agent exposure. Additional genetic techniques can then be used to identify mechanisms underlying resistance and sensitivity, with the ultimate goal of developing more effective and targeted therapies. Here, we discuss the available literature on strain and selected line differences in cholinesterase activity levels and response to nerve agent-induced toxicity and seizures. We also discuss the available cholinesterase and toxicity literature across different non-human primate species. The available data suggest that robust genetic differences exist in cholinesterase activity, nerve agent-induced toxicity, and chemical-induced seizures. Available cholinesterase data suggest that acetylcholinesterase activity differs across strains, but are limited by the paucity of carboxylesterase data in strains and selected lines. Toxicity and seizures, two outcomes of nerve agent exposure, have not been fully evaluated for genetic differences, and thus further studies are required to understand baseline strain and selected line differences.
Collapse
|
7
|
Wang T, Papoutsi M, Wiesmann M, DeCristofaro M, Keselica MC, Skuba E, Spaet R, Markovits J, Wolf A, Moulin P, Pognan F, Vancutsem P, Petryk L, Sutton J, Chibout SD, Kluwe W. Investigation of Correlation Among Safety Biomarkers in Serum, Histopathological Examination, and Toxicogenomics. Int J Toxicol 2011; 30:300-12. [DOI: 10.1177/1091581811401920] [Citation(s) in RCA: 25] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/04/2023]
Abstract
This article addresses the issue of miscorrelation between hepatic injury biomarkers and histopathological findings in the drug development context. Our studies indicate that the use of toxicogenomics can aid in the drug development decision-making process associated with such miscorrelated data. BLZ945 was developed as a Colony-Stimulating Factor 1 Receptor (CSF-1R) inhibitor. Treatment of BLZ945 in rats and monkeys increased serum alanine aminotransferase (ALT) and aspartate transaminase (AST). However, liver hypertrophy was the only histopathological liver finding in rats, and there was no change in the livers of monkeys. Longer treatment of BLZ945 in rats for 6 weeks caused up to 6-fold elevation of ALT, yet hepatocyte necrosis was not detected microscopically. Toxicogenomic profiling of liver samples demonstrated that the genes associated with early response to liver injury, apoptosis/necrosis, inflammation, oxidative stress, and metabolic enzymes were upregulated. Studies are ongoing to evaluate the mechanisms underlying BL945-induced ALT and AST elevations.
Collapse
Affiliation(s)
- Tao Wang
- Translational Sciences, Novartis Institute of Biomedical Research, Emeryville, CA, USA
| | - Maria Papoutsi
- Translational Sciences, Novartis Institute of Biomedical Research, Basel, Switzerland
| | - Marion Wiesmann
- Oncology, Novartis Institute of Biomedical Research, Basel, Switzerland
| | - Marc DeCristofaro
- Translational Sciences, Novartis Institute of Biomedical Research, Emeryville, CA, USA
| | - M. Craig Keselica
- Translational Sciences, Novartis Institute of Biomedical Research, Emeryville, CA, USA
| | - Elizabeth Skuba
- Translational Sciences, Novartis Institute of Biomedical Research, Emeryville, CA, USA
| | - Robert Spaet
- Translational Sciences, Novartis Institute of Biomedical Research, Emeryville, CA, USA
| | - Judit Markovits
- Translational Sciences, Novartis Institute of Biomedical Research, Emeryville, CA, USA
| | - Armin Wolf
- Translational Sciences, Novartis Institute of Biomedical Research, Basel, Switzerland
| | - Pierre Moulin
- Translational Sciences, Novartis Institute of Biomedical Research, Basel, Switzerland
| | - Francois Pognan
- Translational Sciences, Novartis Institute of Biomedical Research, Basel, Switzerland
| | - Paul Vancutsem
- Translational Sciences, Novartis Institute of Biomedical Research, Emeryville, CA, USA
| | - Lew Petryk
- Oncology, Novartis Pharma, Emeryville, CA, USA
| | - James Sutton
- Translational Sciences, Novartis Institute of Biomedical Research, Emeryville, CA, USA
| | - Salah-Dine Chibout
- Translational Sciences, Novartis Institute of Biomedical Research, Basel, Switzerland
| | - William Kluwe
- Translational Sciences, Novartis Institute of Biomedical Research, Emeryville, CA, USA
| |
Collapse
|
8
|
Cardiac damage in acute organophosphate poisoning in rats: Effects of atropine and pralidoxime☆. Am J Emerg Med 2009; 27:169-75. [DOI: 10.1016/j.ajem.2008.01.016] [Citation(s) in RCA: 17] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/06/2007] [Revised: 01/17/2008] [Accepted: 01/24/2008] [Indexed: 11/21/2022] Open
|
9
|
Genovese RF, Benton BJ, Shippee SJ, Jakubowski EM, Bonnell JC. Effects of low-level inhalation exposure to cyclosarin on learned behaviors in Sprague-Dawley rats. JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH. PART A 2006; 69:2167-80. [PMID: 17062507 DOI: 10.1080/15287390600748153] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/12/2023]
Abstract
Behavioral and biochemical effects of low-level whole-body inhalation exposure to the chemical warfare nerve agent cyclosarin (GF) were evaluated. Sprague-Dawley rats were first trained on a variable-interval, 56-s (VI56) schedule of food reinforcement. The VI56 schedule specifies that a single lever press, following an average interval of 56 s, produces food reinforcement (i.e., a single food pellet). Subjects were then exposed to GF vapor at concentrations of 1.6-5.2 mg/m3, or air control, for 60 min. Following exposures, performance on the VI56 and acquisition and maintenance of a radial-arm maze (RAM) spatial memory task were evaluated during 55 test sessions over approximately 11 wk. GF exposures produced miosis in all subjects and other mild clinical signs of toxicity at the highest concentration. Convulsions were not observed in any subjects. GF exposures produced concentration-dependent decreases in acetylcholinesterase and butyrylcholinesterase activity. Additionally, blood assays revealed concentration-dependent levels of regenerated GF, thus verifying systemic exposure. The largest concentration of GF disrupted performance on the VI56 task. The deficit, however, resolved by the third postexposure test session. All subjects acquired, and maintained, performance on the RAM task, and no significant differences were seen as a result of GF exposure. No delayed effects from exposures were observed. These results demonstrate that, in rats, inhalation exposure to GF at levels below those producing convulsions and other severe clinical signs of toxicity may produce performance deficits on learned behaviors, but the deficits appear to not be persistent.
Collapse
Affiliation(s)
- Raymond F Genovese
- Division of Psychiatry and Neuroscience, Walter Reed Army Institute of Research, Silver Spring, Maryland, USA.
| | | | | | | | | |
Collapse
|
10
|
Lundy PM, Raveh L, Amitai G. Development of the Bisquaternary Oxime HI-6 Toward Clinical Use in the Treatment of Organophosphate Nerve Agent Poisoning. ACTA ACUST UNITED AC 2006; 25:231-43. [PMID: 17288495 DOI: 10.2165/00139709-200625040-00004] [Citation(s) in RCA: 70] [Impact Index Per Article: 3.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/02/2022]
Abstract
The traditional therapeutic treatment of organophosphate cholinesterase inhibitor (nerve agents) poisoning consists of co-treatment with an antimuscarinic (atropine) and a reactivator of inhibited acetylcholinesterase (AChE), which contains a nucleophilic oxime function. Two oximes are presently widely available for clinical use, pralidoxime and obidoxime (toxogonin), but both offer little protection against important nerve agent threats. This has highlighted the real need for the development and availability of more effective oximes for human use, a search that has been going on for up to 30 years. However, despite the demonstration of more effective and safe oximes in animal experiments, no additional oximes have been licensed for human use. HI-6, (1-[[[4(aminocarbonyl)-pyridinio]methoxy]methyl]-2(hydroxyimino)pyridinium dichloride; CAS 34433-31-3) has been studied intensively and has been proved effective in a variety of species including non-human primates and appears from clinical experience to be safe in humans. These studies have led to the fielding of HI-6 for use against nerve agents by the militaries of the Czech republic, Sweden, Canada and under certain circumstances the Organisation for the Prohibition of Chemical Weapons. Nevertheless HI-6 has not been granted a license for clinical use, must be used only under restricted guidelines and is not available for civilian use as far as is known. This article will highlight those factors relating to HI-6 that pertain to the licensing of new compounds of this type, including the mechanism of action, the clinical and pre-clinical demonstration of safety and its efficacy against a variety of nerve agents particularly in non-human primates, since no relevant human population exists. This article also contains important data on the use of HI-6 in baboons, which has not been available previously. The article also discusses the possibility of successful therapy with HI-6 against poisoning in humans relative to doses used in non-human primates and relative to its ability to reactivate inhibited human AChE.
Collapse
Affiliation(s)
- Paul M Lundy
- Therapeutic Response, Medicine Hat, Alberta, Canada
| | | | | |
Collapse
|
11
|
Bajgar J. Organophosphates/nerve agent poisoning: mechanism of action, diagnosis, prophylaxis, and treatment. Adv Clin Chem 2004; 38:151-216. [PMID: 15521192 DOI: 10.1016/s0065-2423(04)38006-6] [Citation(s) in RCA: 500] [Impact Index Per Article: 25.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Abstract
OP/nerve agents are still considered as important chemicals acting on living organisms and are widely used. They are characterized according to their action as compounds influencing cholinergic nerve transmission via inhibition of AChE. Modeling of this action and extrapolation of experimental data from animals to humans is more possible for highly toxic agents than for the OP. The symptoms of intoxication comprise nicotinic, muscarinic, and central symptoms; for some OP/nerve agents, a delayed neurotoxicity is observed. Cholinesterases (AChE and BuChE) are characterized as the main enzymes involved in the toxic effect of these compounds, including molecular forms. The activity of both enzymes (and molecular forms) is influenced by inhibitors (reversible, irreversible, and allosteric) and other factors, such as pathological states. There are different methods for cholinesterase determination; however, the most frequent is the method based on the hydrolysis of thiocholine esters and subsequent detection of free SH-group of the released thiocholine. The diagnosis of OP/nerve agent poisoning is based on anamnesis, the clinical status of the intoxicated organism, and on cholinesterase determination in the blood. For nerve agent intoxication, AChE in the red blood cell is more diagnostically important than BuChE activity in the plasma. This enzyme is a good diagnostic marker for intoxication with OP pesticides. Some other biochemical examinations are recommended, especially arterial blood gas, blood pH, minerals, and some other specialized parameters usually not available in all clinical laboratories. These special examinations are important for prognosis of the intoxication, for effective treatment, and for retrospective analysis of the agent used for exposure. Some principles of prophylaxis against OP/nerve agent poisoning comprising the administration of reversible cholinesterase inhibitors such as pyridostigmine (alone or in combination with other drugs), scavengers such as preparations of cholinesterases, some therapeutic drugs, and possible combinations are given. Basic principles of the treatment of nerve agent OP poisoning are described. They are based on the administration of anticholinergics (mostly atropine but some other anticholinergics can be recommended) as a symptomatic treatment, cholinesterase reactivators as a causal treatment (different types but without a universal reactivator against all OP/nerve agents) as the first aid and medical treatment, and anticonvulsants, preferably diazepam though some other effective benzodiazepines are available. New drugs for the treatment are under experimental study based on new approaches to the mechanism of action. Future trends in the complex research of these compounds, which is important not only for the treatment of intoxication but also for the quantitative and qualitative increase of our knowledge of toxicology, neurochemistry, neuropharmacology, clinical biochemistry, and analytical chemistry in general, are characterized.
Collapse
Affiliation(s)
- Jirí Bajgar
- Purkyne Military Medical Academy, Hradec Králové, Czech Republic
| |
Collapse
|
12
|
Lallement G, Demoncheaux JP, Foquin A, Baubichon D, Galonnier M, Clarençon D, Dorandeu F. Subchronic administration of pyridostigmine or huperzine to primates: compared efficacy against soman toxicity. Drug Chem Toxicol 2002; 25:309-20. [PMID: 12173251 DOI: 10.1081/dct-120005893] [Citation(s) in RCA: 22] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
Abstract
Organophosphonate (OP) nerve agents, such as soman, are potent irreversible inhibitors of central and peripheral acetylcholinesterases (AChEs). Pre-treatment of OP poisoning relies on the subchronic administration of a reversible AChE inhibitor. In the present limited study, the protective effects against soman toxicity of such compounds, i.e., the current pre-treatment pyridostigmine and huperzine, a proposed pre-treatment, are compared in primates. This is the first time primates are used to study the potential of pre-treatment with hyperzine. Indeed, previous studies with huperzine used nonprimate models which are not the most appropriate for pre-treatment in humans. Each medication is given via a subcutaneous mini-osmotic pump for 6 days at a delivery rate providing about 20% inhibition of red cell AChE activity. In this trial with only four primates, huperzine selectively inhibits red cell AChE activity whereas pyridostigmine also inhibits plasma butyrylcholinesterase (BuChE). This latter may act as endogenous scavenger of OP compounds helping to confer additional protection against OPs. During intoxication, the cumulative dose of soman needed to produce convulsions and epileptic activity is 1.55-fold higher in the animals pre-treated with huperzine compared to those pre-treated with pyridostigmine. Thus, replacing PYR by HUP for a subchronic pre-treatment of primates gives them better tolerance to the epileptic effects of soman.
Collapse
Affiliation(s)
- Guy Lallement
- Unité de Neuropharmacologie, CRSSA, BP. 87, 38702 La Tronche, France.
| | | | | | | | | | | | | |
Collapse
|
13
|
Olson CT, Blank JA, Menton RG. Neuromuscular effects of low level exposures to Sarin, pyridostigmine, DEET, and chlorpyrifos. Drug Chem Toxicol 1999; 21 Suppl 1:149-69. [PMID: 10028408 DOI: 10.3109/01480549809007408] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]
Abstract
A study is being initiated to investigate subtle neurobehavioral effects and neuropathology in rats due to exposure to combinations of low levels of Sarin (GB), N,N-diethyl-m-toluamide (DEET), chlorpyrifos (CPF), and pyridostigmine bromide (PB). A similar study is being initiated in rhesus monkeys to investigate neurophysiologic effects and neuromuscular pathology due to exposure to a combination of GB, DEET, CPF, and PB, along with vaccination with botulinum toxoid. A description of these studies is presented.
Collapse
Affiliation(s)
- C T Olson
- Battelle Memorial Institute, Medical Research and Evaluation Facility, Columbus, OH 43201-2693, USA
| | | | | |
Collapse
|